BALAJI AMINES LIMITED

Balaji Amines Limited's investor presentation for Q1 FY27 highlighted a strong operational and financial performance, with resilient margins supported by improving demand across key industries. Management reported the commissioning of India's first commercial-scale 100,000 TPA Dimethyl Ether plant, marking a significant milestone in diversifying into new-age chemicals and alternate fuels. The presentation detailed financial metrics, showing a year-on-year revenue increase of 25.73% to INR 461 Cr and a 110.19% rise in profit after tax to INR 78 Cr. Management noted that expansion projects for N-Methyl Morpholine and Acetonitrile are on track for commissioning by the end of the financial year. The company emphasized its commitment to import substitution and sustainable growth, backed by a healthy order pipeline and disciplined execution. The presentation also outlined the company's diversified product portfolio and strategic initiatives aimed at enhancing operational efficiency and market presence.

Management emphasized strong performance and growth initiatives.